[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370623-105":59,"doc-detail-370623-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","high-grade-non-muscle-invasive-urothelial-carcinoma-in-dogs-and-humans-share-specific-expression-of-integrin-a5b1","High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin a5b1","","Urothelial carcinoma (UC) is a major cause of bladder cancer in both humans and dogs, with a shared burden of genetic alterations and tumor markers. Residual high-grade disease drives recurrence and progression, yet early detection and targeted treatment remain unmet needs. This study evaluates whether integrin a5b1 expression serves as a species-shared marker of malignant high-grade non-muscle invasive UC using immunohistochemistry in human bladder samples and canine tumor specimens.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/high-grade-non-muscle-invasive-urothelial-carcinoma-in-dogs-and-humans-share-specific-expression-of-integrin-a5b1/370623/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/high-grade-non-muscle-invasive-urothelial-carcinoma-in-dogs-and-humans-share-specific-expression-of-integrin-a5b1/370623.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study focus on?","Question",{"text":112,"@type":113},"It targets residual high-grade urothelial carcinoma after optimal treatment, which is responsible for relapse and disease progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was integrin a5b1 expression measured?",{"text":117,"@type":113},"Integrin a5b1 expression was determined by immunohistochemistry in human bladder tissues across grades and in canine bladder tumor specimens.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings regarding integrin a5b1?",{"text":121,"@type":113},"Integrin a5b1 was absent in inflammatory and benign conditions and in low/intermediate-grade NMIBC, but was identified as a specific marker in malignant cells of the urothelium in high-grade NMIBC in humans and all canine high-grade NMIBC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370623,1790218017,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","TYPE Original Research PUBLISHED 28 May 2025  \nDOI 10.3389/fonc.2025.1590073  \nOPEN ACCESS  \nEDITED BY  \nFrancesca Sanguedolce, University of Foggia, Italy  \nREVIEWED BY  \nElisabeth Huijbers,  \nVU Medical Center, Netherlands Rajesh Kumar,  \nKerala University of Health Sciences, India  \n*CORRESPONDENCE  \nMassimo Alfano  \n [alfano.massimo@hsr.it](alfano.massimo@hsr.it)  \nRECEIVED 08 March 2025  \nACCEPTED 24 April 2025  \nPUBLISHED 28 May 2025  \nCORRECTED 25 June 2025  \nCITATION  \nLucianò R, Colecchia M, Sanvito F, Locatelli I, Venegoni C, Di Coste A, Zani DD, Stranieri A, Giudice C, Rigillo A, Gambini M, Montorsi F, Salonia A, Moschini M and Alfano M (2025) High-grade non-muscle invasive urothelial carcinoma in dogs and humans sharespeciﬁc expression of integrin a5b1.  \nFront. Oncol. 15:1590073 .  \ndoi: 10.3389/fonc.2025.1590073  \nCOPYRIGHT  \n© 2025 Lucianò, Colecchia, Sanvito, Locatelli, Venegoni, Di Coste, Zani, Stranieri, Giudice, Rigillo, Gambini, Montorsi, Salonia, Moschini and Alfano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nHigh-grade non-muscle invasive urothelial carcinoma in dogs and humans share speciﬁc expression of integrin a 5b1  \nRoberta Lucianò 1, Maurizio Colecchia 1,2, Francesca Sanvito 1, Irene Locatelli 3, Chiara Venegoni 3, Alessia Di Coste 3, Davide Danilo Zani 4, Angelica Stranieri 4, Chiara Giudice 4, Antonella Rigillo 5, Matteo Gambini 5, Francesco Montorsi 2,5, Andrea Salonia 2,3, Marco Moschini 3 and Massimo Alfano 3*  \n1 Department of Pathology, Istituto di Ricovero e Cura a Caratterle Scientiﬁco (IRCCS) San Raffaele Scientiﬁc Institute, Milan, Italy, 2 Università Vita-Salute San Raffaele, Milan, Italy, 3 Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricovero e Cura a Caratterle Scientiﬁco (IRCCS) San Raffaele Scientiﬁc Institute, Milan, Italy, 4 Department of Veterinary Medicine and Animal Science, University of Milan, Lodi, Italy, 5 I-Vet Diagnostica Veterinaria, Brescia, Italy  \nObjective: Urothelial carcinoma (UC) accounts for more than 90% of all bladder cancers both in humans and dogs. Human and canine UC share many genetic mutations and tumor markers and clinical and therapeutic interventions. The unmet clinical needs are similar such as the early detection and treatment of the high-grade residual disease responsible for tumor recurrence and progression. The aim of this study was to investigate the expression of the a5b1 integrin and its speciﬁcity in high-grade UC in humans and dogs, a marker recently reported in the human bladder in situ carcinoma and murine model of orthotopic bladder cancer.  \nMethods: Expression of integrin a5b1 was established by immunohistochemistry in 67 human bladder samples [four non-tumor tissues, 10 low-grade, 10 intermediate-grade, and 43 high-grade non-muscle invasive bladder cancer (NMIBC)] and 12 canine bladder tumor specimens.  \nResults: The a5b1 integrin was not expressed by urothelial cells in the conditions of inﬂammatory cystitis, actinic cystitis, benign hyperplasia, and low/intermediate grade NMIBC; it was identiﬁed as a speciﬁc marker expressed only by the malignant cells in the urothelium in 81% of human and all canine high-grade NMIBC.  \nConclusions: The expression of a5b1 integrin is a speciﬁc marker of high-grade UC located in the urothelium of humans and dogs and might be tested for targeted delivery of contrast agents or drugs. Given the close similarity between high-grade UC in humans and dogs, basic research in the two species and comparative data analysis could strengthen the prospects for ","cbCaisCdVnKNBjyF","https://ap.wps.com/l/cbCaisCdVnKNBjyF","pdf",4979850,11,"English","# Introduction\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What clinical problem does the study focus on?\",\"answer\":\"It targets residual high-grade urothelial carcinoma after optimal treatment, which is responsible for relapse and disease progression.\"},{\"question\":\"How was integrin a5b1 expression measured?\",\"answer\":\"Integrin a5b1 expression was determined by immunohistochemistry in human bladder tissues across grades and in canine bladder tumor specimens.\"},{\"question\":\"What were the key findings regarding integrin a5b1?\",\"answer\":\"Integrin a5b1 was absent in inflammatory and benign conditions and in low/intermediate-grade NMIBC, but was identified as a specific marker in malignant cells of the urothelium in high-grade NMIBC in humans and all canine high-grade NMIBC.\"}]","High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin a5b1 | PDF",1790189504,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d5cb06eac5849f809eaf5067e19857f.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11b7169109fd11546728e3f73fd2ee12.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/311b3bd894060bf01f6a669a949a4cae.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43233e92fa41dd4e0191ddecfeb858af.webp",980,1385]